1 |
Lacey, D.L., Timms, E., Tan, H.L., Kelley, M.J., Dunstan, C.R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998). Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176.
DOI
ScienceOn
|
2 |
Lee, J., and Kim, M.S. (2007). The role of GSK3 in glucose homeostasis and the development of insulin resistance. Diabetes Res. Clin. Pract. 77 Suppl 1, S49-57.
DOI
ScienceOn
|
3 |
Moon, J.B., Kim, J.H., Kim, K., Youn, B.U., Ko, A., Lee, S.Y., and Kim, N. (2012). Akt induces osteoclast differentiation through regulating the GSK3beta/NFATc1 signaling cascade. J. Immunol. 188, 163-169.
DOI
ScienceOn
|
4 |
Roffey, J., Rosse, C., Linch, M., Hibbert, A., McDonald, N.Q., and Parker, P.J. (2009). Protein kinase C intervention: the state of play. Curr. Opin. Cell Biol. 21, 268-279.
DOI
ScienceOn
|
5 |
Saito, N., Kikkawa, U., and Nishizuka, Y. (2002). The family of protein kinase C and membrane lipid mediators. J. Diabetes Complications 16, 4-8.
DOI
ScienceOn
|
6 |
Schiaffino, S., and Mammucari, C. (2011). Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models. Skelet. Muscle 1, 4.
DOI
|
7 |
Steinberg, S.F. (2008). Structural basis of protein kinase C isoform function. Physiol. Rev. 88, 1341-1378.
DOI
ScienceOn
|
8 |
Takayanagi, H., Ogasawara, K., Hida, S., Chiba, T., Murata, S., Sato, K., Takaoka, A., Yokochi, T., Oda, H., Tanaka, K., et al. (2000). Tcell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408, 600-605.
DOI
ScienceOn
|
9 |
Fang, X., Yu, S., Tanyi, J.L., Lu, Y., Woodgett, J.R., and Mills, G.B. (2002). Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase Cdependent intracellular pathway. Mol. Cell. Biol. 22, 2099-2110.
DOI
|
10 |
Geraldes, P., and King, G.L. (2010). Activation of protein kinase C isoforms and its impact on diabetic complications. Circ. Res.106, 1319-1331.
DOI
ScienceOn
|
11 |
Goode, N., Hughes, K., Woodgett, J.R., and Parker, P.J. (1992). Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes. J. Biol. Chem. 267, 16878-16882.
|
12 |
Jang, H.D., Shin, J.H., Park, D.R., Hong, J.H., Yoon, K., Ko, R., Ko, C.Y., Kim, H.S., Jeong, D., Kim, N., et al. (2011). Inactivation of glycogen synthase kinase-3beta is required for osteoclast differentiation. J. Biol. Chem. 286, 39043-39050.
DOI
ScienceOn
|
13 |
Jang, H.D., Noh, J.Y., Shin, J.H., Lin, J.J., and Lee, S.Y. (2013). PTEN regulation by the Akt/GSK-3beta axis during RANKL signaling. Bone 55, 126-131.
DOI
ScienceOn
|
14 |
Kawakami, T., Kawakami, Y., and Kitaura, J. (2002). Protein kinase C beta (PKC beta).: normal functions and diseases. J. Biochem. 132, 677-682.
DOI
ScienceOn
|
15 |
Kim, J.H., Kim, K., Youn, B.U., Jin, H.M., and Kim, N. (2010). MHC class II transactivator negatively regulates RANKL-mediated osteoclast differentiation by downregulating NFATc1 and OSCAR. Cell. Signal. 22, 1341-1349.
DOI
ScienceOn
|
16 |
Lee, S.W., Kwak, H.B., Chung, W.J., Cheong, H., Kim, H.H., and Lee, Z.H. (2003). Participation of protein kinase C beta in osteoclast differentiation and function. Bone 32, 217-227.
DOI
ScienceOn
|
17 |
Crabtree, G.R., and Olson, E.N. (2002). NFAT signaling: choreographing the social lives of cells. Cell 109, S67-79.
DOI
ScienceOn
|
18 |
Anderson, D.M., Maraskovsky, E., Billingsley, W.L., Dougall, W.C., Tometsko, M.E., Roux, E.R., Teepe, M.C., DuBose, R.F., Cosman, D., and Galibert, L. (1997). A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175-179.
DOI
ScienceOn
|
19 |
Boyle, W.J., Simonet, W.S., and Lacey, D.L. (2003). Osteoclast differentiation and activation. Nature 423, 337-342.
DOI
ScienceOn
|
20 |
Choi, H.K., Kang, H.R., Jung, E., Kim, T.E., Lin, J.J., and Lee, S.Y. (2013). Early estrogen-induced gene 1, a novel RANK signaling component, is essential for osteoclastogenesis. Cell Res. 23, 524-536.
DOI
|
21 |
Doble, B.W., and Woodgett, J.R. (2003). GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116, 1175-1186.
DOI
ScienceOn
|
22 |
Vilimek, D., and Duronio, V. (2006). Cytokine-stimulated phosphorylation of GSK-3 is primarily dependent upon PKCs, not PKB. Biochem. Cell Biol. 84, 20-29.
DOI
ScienceOn
|
23 |
Hogan, P.G., Chen, L., Nardone, J., and Rao, A. (2003). Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17, 2205-2232.
DOI
ScienceOn
|
24 |
Wong, B.R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., Kalachikov, S., Cayani, E., Bartlett, F.S., 3rd, Frankel, W.N., et al. (1997). TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272, 25190-25194.
DOI
ScienceOn
|
25 |
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998). Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95, 3597-3602.
DOI
ScienceOn
|
26 |
Suda, T., Jimi, E., Nakamura, I., and Takahashi, N. (1997). Role of 1 alpha,25-dihydroxyvitamin D3 in osteoclast differentiation and function. Methods Enzymol. 282, 223-235.
DOI
|
27 |
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M.T., and Martin, T.J. (1999). Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20, 345-357.
DOI
|
28 |
Takayanagi, H. (2007). Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7, 292-304.
DOI
ScienceOn
|
29 |
Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J., et al. (2002). Induction and activation of the transcription factor NFATc1 (NFAT2). integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889-901.
DOI
ScienceOn
|
30 |
Tan, S.L., and Parker, P.J. (2003). Emerging and diverse roles of protein kinase C in immune cell signalling. Biochem. J. 376, 545-552
DOI
ScienceOn
|
31 |
Wang, J., Wang, N., Xie, J., Walton, S.C., McKown, R.L., Raab, R.W., Ma, P., Beck, S.L., Coffman, G.L., Hussaini, I.M., et al. (2006a). Restricted epithelial proliferation by lacritin via PKCalphadependent NFAT and mTOR pathways. J. Cell Biol. 174, 689-700.
DOI
ScienceOn
|
32 |
Zhu, T., Tsuji, T., and Chen, C. (2010). Roles of PKC isoforms in the induction of apoptosis elicited by aberrant Ras. Oncogene 29, 1050-1061.
DOI
ScienceOn
|
33 |
Wang, Q., Zhou, Y., and Evers, B.M. (2006b). Neurotensin phosphorylates GSK-3alpha/beta through the activation of PKC in human colon cancer cells. Neoplasia 8, 781-787.
DOI
|
34 |
Kobayashi, N., Kadono, Y., Naito, A., Matsumoto, K., Yamamoto, T., Tanaka, S., and Inoue, J. (2001). Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J. 20, 1271-1280.
DOI
ScienceOn
|
35 |
Kim, H., Choi, H.K., Shin, J.H., Kim, K.H., Huh, J.Y., Lee, S.A., Ko, C.Y., Kim, H.S., Shin, H.I., Lee, H.J., et al. (2009). Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice. J. Clin. Invest. 119, 813-825.
DOI
ScienceOn
|